Impact of body mass index in the results after primary angioplasty in patients with ST segment elevation acute myocardial infarction

Acute Cardiac Care

Volumn 13, Issue 3, 2011, Pages 123-128

  Timóteo, Ana Teresa ^a   Ramos, Ruben ^a   Toste, Alexandra ^a   Oliveira, José Alberto ^a   Ferreira, Maria Lurdes ^a   Ferreira, Rui Cruz ^a  

^a HOSPITAL DE SANTA MARTA   (Portugal)

Author keywords

Body mass index; Primary angioplasty; ST elevation acute myocardial infarction

Indexed keywords

ADULT; ANGIOPLASTY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BODY MASS INDEX; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; PORTUGAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 80052456791     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.3109/17482941.2011.606469     Document Type: Article

References (25)

1. Sholte op 1. Reimer WJM, Gitt AK, Boersma E, Simoons ML (eds). Cardiovascular Diseases in Europe. Euro Heart Survey. Sophia Antipolis, France: European Society of Cardiology; 2006. pp 16 - 7.
2. Calle EE, Th un MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999;341:1097-105.
3. W ilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: Th e Framingham experience. Arch Intern Med. 2002;162: 1867-72.
4. H erbert HB, Feinleid M, McNamara PM, Castel WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham heart study. Circulation 1983;67:968-77.
5. Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE., et al. Th e impact f obesity on the short-term and long-term outcomes aft er percutaneous coronary intervention: Th e obesity paradox? J Am Coll Cardiol. 2002;39:578-84.
6. Oreopoulos A, Padwal R, Norris CM. Mullen JC, Pretorius V, Kalantar-Zadeh K. Eff ect of obesity on short- and long-term mortality post coronary revascularization: A meta-analysis. Obesity 2008;16:442-50.
7. B yrne J, Spence MS, Fretz E, Mildenberger R, Chase A, Berry B., et al. Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry). Am J Cardiol. 2009;103:507-11.
8. Hastie CE, Padmanabhan S, Slack R, Pell AC, Oldroyd KG, Flapan AD., et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J. 2010;31:222-6.
9. O reopoulos A, McAlister FA, Kalentar-Zadeh K, Padwal R, Ezekowitz JA, Sharma AM., et al. Th e relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: A report from APPROACH. Eur Heart J. 2009;30:2584-92.
10. W ang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX., et al. Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents. Heart 2009;1587-92.
11. M ehta RH, O'Neill WW, Harjai KJ, Cox A, Brodie BR, Boura J., et al. Prediction of one-year mortality among 30-day survivors aft er primary percutaneous coronary interventions. Am J Cardiol. 2006;97:817-22.
12. N ikolsky E, Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE., et al. Impact of body mass index on outcome aft er primary angioplasty in acute myocardial infarction. Am Heart J. 2006;151:168-75.
13. Eisenstein EL, McGuire DK, Bhapkar M, Krostinsson A, Hochman JS, Kong DF., et al. Elevated body mass index and intermediate- term clinical outcomes aft er acute coronary syndromes. Am J Med. 2005;118:981-90.
14. K ragelund C, Hassager C, Hildebrand P, Torp-Pederson C, Kober L, TRACER Study Group. Impact of obesity on long-term prognosis following acute myocardial infarction. Int J Cardiol. 2005;98:123-31.
15. M ehta L, Devlin W, McCullough PA, O'Neill WW, Skelding KA, Stone CW., et al. Impact of body mass index on outcomes aft er percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol. 2007;99:906-10.
16. N drepepa G, Keta D, Byrne RA, Schulz S, Mehilli J, Seyfarth M., et al. Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention. Heart Vessels 2010;25:27-34.
17. K osuge M, Kimura K, Kojima S, Sakamoto T, Ishihara M, Asada Y., et al. Impact of body mass index on in-hospital outcomes aft er percutaneous coronary intervention for ST segment elevation acute myocardial infarction. Circ J. 2008;72:521-5.
18. N icoletti I, Cicoira M, Morando G, Benazzi C, Prati D, Morani G., et al. Impact of body mass index on short-term outcome aft er acute myocardial infarction: Does excess body weight have a paradoxical protective role? Int J Cardiol. 2006;107:395-99
19. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
20. Reuser M, Bonneux L, Willekens F. Th e burden of mortality of obesity at middle and old age is small. A life-table analysis of the US Health and Retirement Survey. Eur J Epidemiol. 2008;23:601-7.
21. Lloyd-Jones D, Adams R, Carnethon M, 21. De Simone G, Ferguson TB, Flegal K., et al. Heart disease and stroke statistics 2009 update. A report from the American Heart Association statistics committee and stroke statistics sub-committee. Circulation 2009;119:e21-e181.
22. M cGee DL. Body mass index and mortality: A meta-analysis based on personal-level data from twenty-six observational studies. Ann Epidemiol. 2005;15:87-97.
23. R igalleau V, Lasseur C, Perlemoine C., et al. Cockcroft - Gault formula is biased by body weight in diabetic patients with renal impairment. Metabolism 2006;55:108-12.
24. Lincoff AM, Kleiman NJ, Kereiakes DJ, Feit F, Bittl JA, Jackman JD., et al. for the REPLACE-2 Investigators. Long-term effi cacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous revascularization: RELACE-2 randomized trial. JAMA 2004;292:696-703.
25. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F., et al. Eff ect of potentially modifi able risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study); case-control study. Lancet. 2004;364:937-52.